ABSTRACT Significant in vivo stimulation of granulopoiesis was induced in mice by the administration of an extract from the urine of patients with aplastic anemia (AA). Sialic acid has been identified as an important molecular component for the in vivo biological activity of this granulopoietic factor, "granulopoietin," which is distinct and different from endotoxin. Urine from patients with AA was successively fractionated by Sephadex G-50 and DEAE-cellulose chromatography. The resultant extract, which we refer to as AA urinary extract, contained =44 international units of erythropoietin per A unit of protein and induced 15,000 colonies of granulocyte/macrophage precursor cells (granulocyte/ macrophage colony-forming units, CFU-gm) per A unit of protein with mouse bone marrow. Eight daily intraperitoneal injections of this extract in mice induced a 6.2-fold increase in peripheral blood granulocytes and a 14.6-fold increase of splenic CFU-gm, with concomitant increases in the proliferation rates of CFU-gm in both bone marrow and spleen. Pretreatment of the AA urinary extract with sialidase significantly diminished these granulopoietic effects in vivo (P < 0.001). In contrast, both extracts (i.e., native AA and sialidase-treated AA urinary extracts) revealed high granulocyte/ macrophage colony-stimulating factor activity in vitro when clonal assays were performed with mouse bone marrow. Increased in vivo and in vitro granulopoietic activities were found in the concanavalin A "break-through" fraction, indicating that these activities were due to protein(s) that did not bind to the lectin. These results reveal that this urinary extract from patients with AA is capable of inducing significant granulopoiesis in mice and that sialic acid is an important component in the maintenance of this granulopoietic effect in vivo but not in vitro Granulocyte/macrophage colony-stimulating factor (gm-CSF), initially described by Bradley and Metcalf (1) 
Granulocyte/macrophage colony-stimulating factor (gm-CSF), initially described by Bradley and Metcalf (1), Ichikawa et al (2) , and Pluznik and Sachs (3) , is a glycoprotein that stimulates the proliferation and differentiation of granulocyte/macrophage precursor cells (granulocyte/macrophage colony-forming units, CFU-gm) in vitro. In vivo hematopoietic stimulation, however, has not been firmly demonstrated with the same gm-CSF preparations.
Many sialic acid-containing glycoproteins [e.g., plasma proteins such as ceruloplasmin and fetuin (4) ; hormones such as human chorionic gonadotropin (5) and erythropoietin (6, 7) ; and enzymes (8, 9) ] can normally survive in the circulation only when fully sialated, whereas even partial desialation results in their prompt in vivo inactivation and clearance.
Therefore, we examined the effect of the sialic acid content of extracts from the urine of patients with aplastic anemia (AA), which we term AA urinary extracts, on in vivo granulopoiesis in mice. These extracts were either pretreated with sialidase to remove sialic acid or they were left untreated as native extracts.
In addition to the importance of sialic acid, the relationship between the granulopoietic activity of the extract and its affinity to concanavalin A (Con A)-Sepharose was examined.
MATERIALS AND METHODS Preparation of Urinary Extract. The urine from patients with AA was collected in sterile vessels. Because all patient samples contained elevated levels of erythropoietin, they were pooled and handled as follows. Unless otherwise indicated, all procedures during protein fractionation were performed at 40C. Urinary extracts from patients with AA and from healthy donors were prepared principally by the method described by Kaneko et aL (10) and Kawakita et aL (11) for the concentration of erytbropoietin, with slight modifications. This procedure yielded :34 A units of protein from 1 liter of urine; 1 A unit of protein of the patient's urinary extract induced t15,000 CFU-gm colonies with mouse bone marrow and contained 44 units of erythropoietin. CFU-gm assays were performed as reported (12) , and the starved rat was used to assay erythropoietin (13) . Protein was spectrophotometrically measured at 278 nm, and 1.70 A units corresponded to 1.0 mg of protein when measured by the method of Lowry et al. with bovine albumin (Calbiochem) as a standard (14) . All urinary protein measurements were recorded in A units because urine is known to contain a high concentration of Lowry-reagent-positive but nonproteinaceous pigment, which may be misleading. Therefore, the use of A units is a more accurate and sensitive expression of protein derived from human urine. All of the patients with AA enrolled as urinary donors were free from any sign of infectious disease but showed severe pancytopenia in the peripheral blood and bone marrow. The total protein levels in urine from patients with AA were within normal limits.
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RESULTS

Induction of in Vivo Granulopoiesis in Mice with AA Urinary Extracts and the Effects of Sialidase on This
Activity. The effect of urinary extracts on granulopoiesis was examined by counting granulocytes in the peripheral blood of mice. Granulocyte numbers in mice that received native and sialidase-treated AA urinary extracts were significantly increased by day 2 (Fig.  1) . The group of mice that received the native AA urinary extract showed a rapid increase in peripheral blood granulocytes, which reached a maximum by day 8, and then maintained this elevated level through day 14. The group of mice that received sialidase-treated urinary extract responded in a similar manner. However, the increase in peripheral blood granulocytes was less and of shorter duration than with the native AA urinary extract. A summary of the hematological results is shown in Table 1 .
The effects of the native urinary extract of patients with AA on granulopoiesis were 6.2 times that of normal control urinary extract (P < 0.001). Similar responses were observed for total leukocyte numbers, total splenic cellularity, and the numbers of CFU-gm in the spleen. On the other hand, the total nucleated cellularity and the number of CFU-gm in the femur were both initially depressed and then recovered to nearly normal levels by day 14 in mice that were treated with different urinary extracts (data not shown). However, sialidase-treated AA urinary extract induced a lesser effect than did the native AA urinary extract from the same patients. Differential cell counts of peripheral blood showed no significant change in the stage of maturation of circulating granulocytes between day 2 through day 14 in the AA urinary extract-treated mice. There was a slight increase in the number of immature granulocytes at day 2 (-18-23%) compared to the number on day 0 (-9-12%) in the bone marrow of AA urinary extract-treated mice, an increase of both immature and mature granulocytes from days 2 to 8 (=9-18%) compared to the number on day 0 (=2-5%), and an increase in splenic erythroblasts (with native AA urinary extract, 47-27%; with sialidase-treated AA urinary extract, 415-16%) compared to the number on day 0 (5%).
The proliferation rate of CFU-gm measured by [3H]thymidine was higher in the native and sialidase-treated AA urinary extracts of both bone marrow and spleen than in the saline-treated control. TBV measured by 51Cr was increased in mice given the native AA urinary extract, and there were no significant differences in TBV of the other groups ( Table 1 ). The body weights of mice treated with the AA urinary extracts were slightly less than those of controls, but this was not statistically significant. Proc. Nad Acad. Sci. USA 80 (1983) Con A-Sepharose chromatography was performed under the following conditions: 114.154A units ofthe extract was dissolved in 14 ml of initial buffer (0.01 M Tris HCl, pH 8.0/1 mM CaCl2/1 mM MgCl2/0.5 M NaCl) and applied to a lectin column (11.5 x 1.5 cm diameter), which was preequilibrated with the initial buffer. Fraction 1 was obtained with a 300-ml effluent wash with initial buffer, and fraction 2 was from a 200-ml elution with the second buffer (0.1 M methyl-a-D-glucoside in initial buffer). Each fraction was immediately concentrated with ultrafilter Amicon YM-10 and then lyophilized. Each group of six mice received daily intraperitoneal injections for 8 days of either 0.2 ml of saline (control) or of 0.2 ml of the test fraction (0.136 A units per mouse per day). *Mean ± SD.
During the 14 days of treatment, all mice were in good health, and there were no deaths. A dose-dependent effect of AA urinary extract on in vivo granulopoiesis is reflected in Fig. 2 . Remarkable increases (P < 0.001) in spleen weight, leukocytes, blood granulocytes, and total CFU-gm in spleens were observed in mice injected daily with 0.017 A unit of the protein.
The correlation coefficients between 0.017 A unit and 0.272 A unit were 0.9944 for splenic CFU-gm and 0. 9625 for peripheral blood granulocytes.
Induction of in Vivo Granulopoiesis in Mice with Con ASepharose Fractions of Urinary Extract. In order to examine the terminal sugar of the active granulopoietic component in the AA urinary extracts, Con A-Sepharose affinity chromatography was performed (Table 2) . When these preparations were administered to six mice in each group for 8 days, Fraction 1 induced a remarkable increase in granulocyte numbers (P < 0.001), while fraction 2 produced only a modest increase in circulating granulocytes. Because the probable existence of some inhibitors (17, 18) for granulocyte colony-stimulating factor activity was presumed, both Con A fractions were run on hydroxylapatite columns. After this treatment, 75% of CFU-g colonyforming activity was detected in Con A fraction 1 (Fig. 3A) ; on the other hand, 70% of CFU-m colony forming activity was observed in Con A fraction 2 (Fig. 3B) .
Effect of Lipopolysaccharide (LPS) and Sialidase-Treated LPS on in Vivo Granulopoiesis in Mice. Whereas LPS induced a slight in vivo increase of granulopoiesis in mice, treatment of LPS with sialidase did not in any way alter its in vivo activity C(able 3). In addition, sialic acid was not detected by ion-exchange analysis and gas/liquid chromatography on native, sialidase-treated, and acid-hydrolyzed LPS (unpublished data). The combined weight of this evidence indicates that LPS is not responsible for the in vivo granulopoietic effects induced by the AA urinary extracts.
DISCUSSION
AA is a chronic disorder characterized by pancytopenia in the peripheral blood and hypocellularity of the bone marrow. The urine from patients with AA contains elevated stimulating activities for both erythropoiesis (10) and thrombopoiesis (19) when assayed in vivo and in vitro. The present results demonstrate that an extract of urine from patients with AA had granulo- 13 .4 ± 0.4 11.5 ± 0.3 11.6 ± 0.1 Leukocytes x 10-6 per ml 7.7 ± 1.9 16.9 ± 5.1 17.7 ± 2.7 Granulocytes x 10' per ml 1.4 ± 0.6 4.0 ± 1.7 4.0 + 1.8 * Ten micrograms of LPS (Salmonella typhosa) treated or not treated with sialidase was intraperitoneally injected in 0.2 ml of saline daily into BDF1 male mice for 8 days. Each value is the mean ± SD. t One mouse died in this group. poietic activity when assayed in vivo because it induced a remarkable granulocytosis in the peripheral blood and an increase in the splenic CFU-gm pool. Furthermore, our observations clearly reveal that sialic acid is an important component of this urinary extract in the maintenance of its in vivo granulopoietic activity. The biological and chemical properties of the sialidase found in these urinary extracts, which constitute a separate publication, are summarized as follows. Urinary sialidase has a high specific activity, with the optimum pH for activity at 5.3. The molecular weight for this urinary extract sialidase is 37.5 *x 104, which clearly makes it different from both bacterial and viral neuraminidase. Urinary sialidase can destroy the biological activity of urine-containing hematopoietic factors when they are in solution (i.e., urine or urine concentrate) for 48 hr at 40C and pH 5.0.
Sialidase-treated AA urinary extracts and fraction 2 of Con A-Sepharose chromatography had less in vivo granulopoietic activity than that of native AA extract. This activity might remain as a result of: (i) insufficient and partial desialation or (ii) heterogeneous carbohydrate moieties of the AA urinary extract. The former proposition is, however, questionable because about 90% of the bound sialic acid was released from the assay sample by the enzyme treatment. Affinity of glycoproteins to the lectin Con A is dependent upon unmodified. hydroxy groups at the C-3, C-4, and C-6 positions of D-mannopyranose as the terminal sugar (20) . In addition, mannoses that are located near the core of the biantennary carbohydrate structure also have affinity to this lectin, even when the sialic acid residues are fully retained (21, 22) . Furthermore, the biantennary structure of some glycoproteins [e.g., transferrin (4)] confers protection against in vivo clearance even after desialation. This observation regarding the structure of transferrin may account for the in vivo granulopoietic activity of the desialated urinary extract and its retention on Con A-Sepharose columns.
Zuckerman etul. (23) (24) and which is usually used as a standard preparation for the Limulus test, was not detected in our human urinary extracts when measured by gas/liquid chromatography and mass. spectrophotometry; (iv) the mitogenic activity conferred on mouse spleen.cells by this urinary extract is an order of magnitude weaker than that, of LPS; and (v) the molecular weight of the active component of the urinary extract is different from that of LPS (data not shown). All of these data support the proposition that the in vivo granulopoietic activity from our AA urinary extracts is not due to contaminating endotoxin.
